ToPCaP

Aberrant cytoplasmic expression of p63 and prostate cancer mortality.

Dhillon P, Barry M, Stampfer MJ, Perner S, Fiorentino M, Fornari M, Ma J, Fleet J, Kurth T, Loda M, Rubin MA, Mucci LA. Aberrant cytoplasmic expression of p63 and prostate cancer mortality. Cancer Epidemiol Biomarkers Prev 2009 Feb;18(2):595-600. PMCID: PMC2692093